Brind.

A study partnered with GenFleet, conducted in China, had its data presented in Barcelona on August 14, 2025, involving Verastem Oncology.

1 report, 1 independent Updated Aug 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

A study partnered with GenFleet, conducted in China, had its data presented in Barcelona on August 14, 2025, involving Verastem Oncology.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Business WireVerastem Oncology Announces Late-Breaking Abstract from Partner GenFleet Therapeutics’ Study in China of GFH375 (VS-7375) in Advanced Non-Small Cell Lung Cancer at IASLC 2025 World Conference on Lung